Clinical Trial: Pregabalin Open-Label Extension Trial in Patients With Partial Seizures
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Pregabalin BID Open-Label Add-On Trial: A Follow-Up Study To Determine Long-Term Safety and Efficacy in Patients With Partial Seizures
Brief Summary: The primary purpose of the protocol is to evaluate the long-term safety of pregabalin in patients with partial seizures.
Detailed Summary:
Sponsor: Pfizer
Current Primary Outcome: Safety assessments are performed at quarterly visits up until the study is closed.
Original Primary Outcome: Same as current
Current Secondary Outcome: Seizure frequency is assessed throughout the study until the study is closed.
Original Secondary Outcome: Same as current
Information By: Pfizer
Dates:
Date Received: August 30, 2005
Date Started: September 2001
Date Completion: February 2006
Last Updated: July 21, 2006
Last Verified: March 2006